Fellowship Publications

First Author Fellowship Publications


  1. Ulm EA, et al. Developmental functions for the Caenorhabditis elegans sp protein SPTF-3. Mechanisms of Development 2011.
  2. Wittwer JA, et al. Enhancing Mitochondrial Respiration Suppresses Tumor Promoter TPA Induced PKM2 Expression and Cell Transformation in Skin Epidermal JB6 Cells. Cancer Prev Res 2011.
  3. Dworkin M, et al. Dramatic reduction of dimensionality in large biochemical networks owing to strong pair correlations. Journal of the Royal Society Interface 2012.
  4. Kauffman KJ, et al. Optimization of Rapamycin-Loaded Acetalated Dextran Microparticles for Immunosuppresion. Int. J. Pharm 2012.
  5. Kauffman KJ, et al. Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product. ACS Appl. Mater. Interfaces 2012.
  6. Mitra K, et al. Indocyanine-green-loaded microballoons for biliary imaging in cholecystectomy. J Biomed Opt 2012.
  7. Moore S, et al. Cardiac Involvement in Hereditary Ataxias. Journal of Child Neurology 2012.
  8. Collins SM, et al. Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC. Cancer Immunol Immunother 2013.


  1. Ge Z, et al. Nuclear Hat1p complex (NuB4) components participate in DNA repair-linked chromatin reassembly. J Biol Chem 2011.
  2. Gonzalez-Escobedo G, et al. Chronic and Acute Infection of the Gallbladder by Salmonella. Understanding the Carrier State. Nature Reviews of Microbiology 2011.
  3. Machemer K, et al. Interplay of MYB factors in differential cell expansion, and consequences for tomato fruit development. The Plant Journal 2011.
  4. Riley M, et al. NOTCH1 missense alleles associated with left ventricular outflow tract defects exhibit impaired receptor processing and defective EMT. Biophys Acta-Molecular Basis of Disease 2011.
  5. Wang B, et al. Role of cancer stem cells in hepatocarcinogenesis. Genome Medicine 2011.
  6. Zhou C, et al. Design, synthesis of new lipid-like molecules for efficient small interfering RNA (siRNA) delivery and study of their cellular entry pathways. The AAPS Journal 2011.
  7. Zhou C, et al. Synthesis and characterization of a lipoidal amine-based nanocarrier (LANC) formulation for small interfering RNA (siRNA) delivery. The AAPS Journal 2011.
  8. Ahn-Jarvis JH, et al. Impact of Food Matrix on Isoflavone Metabolism and Cardiovascular Biomarkers in Adults with Hypercholesterolemia. Food and Function 2012.
  9. Chen C, et al. Systematic investigation of insertional and deletional RNA-DNA differences in the human transcriptome. BMC Genomics 2012.
  10. Chen HZ, et al. Canonical and atypical E2Fs regulate the mammalian endocycle. Nat Cell Biol 2012.
  11. Chuang HC, et al. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triplenegative breast cancer cells. Breast Cancer Res Treat 2012.
  12. Dhungel N, et al. Beyond tRNA cleavage: novel essential function for yeast tRNA splicing endonuclease unrelated to tRNA processing. Genes & Development 2012.
  13. Hankey W, et al. Human genetics of colorectal cancer. Molecular Pathogenesis of Colorectal Cancer 2012.
  14. Lee I-J, et al. Contractile-ring assembly in fission yeast cytokinesis: Recent advances and new perspectives. Cytoskeleton 2012.
  15. Liu HW, et al. Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes. Nucleic acid research 2012.
  16. North JA, et al. Regulation of the Nucleosome Unwrapping Rate Controls DNA Accessibility. Nucleic Acids Res 2012.
  17. Riley M, et al. The Many Faces of MDM2 Binding Partners. Genes Cancer 2012.
  18. Wang B, et al. Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1α. Hepatology 2012.
  19. Wu SM, et al. Factor Analytic and Item Response Theory Evaluation of the Penn State Worry Questionnaire with Female Cancer Patients. Quality of Life Research 2012.
  20. Zhou C, et al. Novel lipoidal amine-based nanocarrier formulations for siRNA delivery. Therapeutic delivery 2012.
  21. Zhou C, et al. SPANosomes as delivery vehicles for small interfering RNA (siRNA). Molecular Pharmaceutics 2012.
  22. Zorko NA, et al. Mll-Partial Tandem Duplication and Flt3-Internal Tandem Duplication in a Double Knock-in Mouse Recapitulates Features of Counterpart Human Acute Myeloid Leukemias. Blood 2012.
  23. Ahn-Jarvis JH, et al. Optimizing isoflavone-rich food delivery systems for human clinical trials, In Food and Nutritional Components in Focus. Isoflavones Chemistry, Analysis, Function and Effects. Royal Society of Chemistry Publishing 2013.
  24. Ahn-Jarvis JH, et al. Design and selection of soy breads used for evaluating isoflavone bioavailability in clinical trials. Journal of Agricultural and Food Chemistry 2013.
  25. Arango D, et al. Molecular bases for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci 2013.
  26. Chuang HC, et al. AMPK As A Potential Anticancer Target - Friend or Foe? Curr Pharm Des 2013.
  27. Ge Z, et al. Sites of acetylation on newly synthesized histone H4 are required for chromatin assembly and DNA damage response signaling. Mol Cell Biol 2013.
  28. Gocha ARS, et al. Alternative lengthening of telomeres: Permissive mutations, DNA repair proteins, and tumorigenic progression in mammalian cells. Mut Res 2013.
  29. Gocha ARS, et al. Human sarcomas are mosaic for telomerase-dependent and –independent telomere maintenance mechanisms: Implications for telomere-based therapies. Am J Pathol 2013.
  30. Gonzalez-Escobedo G, et al. Histopathological Analysis of Salmonella Chronic Carriage in the Mouse Hepatopancreatobiliary System. PLoS One 2013.
  31. Gonzalez-Escobedo G, et al. Identification of Salmonella Factors Regulated during Biofilm Formation on Cholesterol Gallstone Surfaces. Infection and Immunity 2013.
  32. Gonzalez-Escobedo G, et al. Gallbladder Epithelium as a Niche for Chronic Salmonella Carriage. Infection and Immunity 2013.
  33. Grierson P, et al. Collaborating functions of the BLM helicase and DNA topoisomerase I in regulating human rDNA transcription. Mutat. Res. 2013.
  34. Hankey W, et al. Familial Adenomatous Polyposis Coli and the APC Tumor Suppressor. Encyclopedia of Cancer Therapeutic Targets 2013.
  35. Jacob AG, et al. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. Neoplasia 2013.
  36. Lucas CR, et al. Prohibitins and the Cytoplasmic Domain of CD86 Cooperate To Mediate CD86 Signaling in B Lymphocytes. The Journal of Immunology 2013.
  37. North JA, et al. ATP-Dependent nucleosome unwrapping catalyzed by human RAD51. Nucleic Acids Research 2013.
  38. Phelan JD, et al. Growth factor independence 1 (Gfi1) Antagonizes a p53-dependent DNA Damage Response Pathway in Lymphoblastic Leukemia. Cancer Cell 2013.
  39. Phelan JD, et al. Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors. PLoS Genet 2013.
  40. Phelan JD, et al. Gfi1 Inhibition and the Future of ALL Management. The Journal of OncoPathology 2013.
  41. Rao SS, et al. Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors. Biomaterials 2013.
  42. Riley M, et al. mir-125a-5p mediated Regulation of Lfng is Essential for the Avian Segmentation Clock. Dev Cell 2013.
  43. Shah KH, et al. Processing body and stress granule assembly occur by independent and differentially regulated pathways in Saccharomyces cerevisiae. Genetics 2013.
  44. Wu SM, et al. Psychometric evaluation of the Perceived Stress Scale in Multiple Sclerosis. ISRN Rehabilitation 2013.
  45. Zhao H, et al. N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. Retrovirology 2013.
  46. Zielinski R, et al. Finite element analysis of traction force microscopy: Influence of cell mechanics, adhesion and morphology. Journal of Biomechanical Engineering 2013.
  47. Zhou C, et al. Comparative cellular pharmacokinetics and pharmacodynamics of siRNA delivery by SPANosomes and by cationic liposomes. Nanomedicine: Nanotechnology, Biology and Medicine 2013.
  48. Fenger JM, et al. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer 2014.
  49. Fenger JM, et al. Canine osteosarcoma – a natural occurring disease to inform pediatric oncology. ILAR 2014.
  50. Govindaraghavan M, et al. The Set1/COMPASS histone H3 methyltransferase helps regulate mitosis together with the CDK1 and NIMA mitotic kinases in Aspergillus nidulans. Genetics 2014.
  51. Govindaraghavan M, et al. Identification of Interphase Functions for the NIMA Kinase Involving Microtubules and the ESCRT Pathway. PLoS Genet 2014.
  52. Govindaraghavan M, et al. The NIMA kinase is required to execute stage specific mitotic functions after initiation of mitosis. Eukaryot Cell 2014.
  53. Hutzen B, et al. Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin. BMC cancer 2014.
  54. Jacob AG, et al. The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. Journal of Biological Chemistry 2014.
  55. Lee I-J, et al. Regulation of SPB-duplication and cytokinesis by centrin-binding protein Sfi1 in fission yeast. Mol Biol Cell 2014.
  56. Maxwell BA, et al. Recent Insight into the Kinetic Mechanisms and Conformational Dynamics of Y-Family DNA Polymerases. Biochemistry 2014.
  57. Maxwell BA, et al. Inter-domain conformational dynamics of a Y-family DNA polymerase during catalysis. Biochemistry 2014.
  58. North JA, et al. Histone H3 phosphorylation near the nucleosome dyad alters chromatin structure. Nucleic Acids Res 2014.
  59. Pringle D, et al. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid specific deletion of Prkar1a and Pten in mice. Journal of Clinical Endocrinology and Metabolism 2014.
  60. Jennifer A. Woyach, M.D.*, Richard R. Furman, M.D.*, Ta-Ming Liu*, et al. Resistance Mechanisms for the Bruton’s Tyrosine Kinase Inhibitor Ibrutinib. The New England Journal of Medicine 2014 *The four first authors contributed equally.
  61. Wang B, et al. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology 2014.
  62. Wei K, et al. Electrical liquid lens driven by an annular membrane. Optics Letters 2014.
  63. Wu J, et al. Healing for destruction: tRNA intron degradation in yeast is a two-step cytoplasmic process catalyzed by tRNA ligase Rlg1 and 5’-to-3’ exonuclease Xrn1. Genes Dev 2014.
  64. Wu SM, et al. Association of the physiological stress response with depressive symptoms in breast cancer patients. Psychosomatic Medicine 2014.
  65. Zhao H, et al. Slit2–Robo4 Pathway Modulates Lipopolysaccharide-Induced Endothelial Inflammation and Its Expression Is Dysregulated during Endotoxemia. Journal of Immunology 2014.


  1. Bid HK, et al. Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia? Indian J Urol 2010.
  2. Eisfeld AK, et al. Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading? Adv Hematol 2011.
  3. Hughes T, et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010.
  4. Lai IL, et al. HDAC10 relieves transcriptional repression by maintaining the deacetylation status of repressors. J Bio Chem 2010.
  5. Senapati S, et al. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Journal of Clinical Pathology 2010.
  6. Ahirwar DK, et al. BCG response prediction with cytokine gene variants and bladder cancer: where we are? J Cancer Res Clin Oncol 2011.
  7. Bid HK, et al. Targeting angiogenesis in childhood sarcomas. Sarcoma 2011.
  8. Bid HK, et al. Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 is reversed by IGF-2. Mol Cancer Ther 2011.
  9. Engelmann NJ, et al. Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene. Adv Nutr 2011. 
  10. Kiss DL, et al. The Exozyme Model: A Continuum of Functionally Distinct Complexes. RNA 2011.
  11. Li J, et al. Applications of Vibrational Spectroscopy in the study of flavin-based photoactive protein. Spectroscopy 2011.
  12. Mims A, et al. Epigenetic Priming: the target? Blood 2011.
  13. Senapati S, et al. MUC4-NIDO domain plays a significant role in MUC4-mediated metastasis of pancreatic cancer cells. Oncogene 2011.
  14. Senapati S, et al. Novel interaction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clinical cancer research 2011.
  15. Balkhi MY, et al. IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis. Blood 2012.
  16. Bid HK, et al. Re: markers predicting response to bacillus calmette-guérin immunotherapy in high-risk bladder cancer patients: a systematic review. Eur Urol 2012.
  17. C.K. Martin, et al. Characterization of Bone Resorption in Novel In Vitro and In Vivo Models of Oral Squamous Cell Carcinoma. Oral Oncology 2012.
  18. Caserta E, et al. In Vivo and In Vitro Analysis of Regulation of the Pheromoneresponsive prgQ Promoter by the PrgX Pheromone Receptor Protein. J Bacteriol 2012.
  19. Chlon T, et al. Cofactor-mediated Restriction of GATA-1 Chromatin Occupancy Coordinates Lineage-specific GeneExpression. Mol. Cell 2012.
  20. Chlon T, et al. Combinatorial regulation of tissue specification by GATA and FOG factors. Development 2012.
  21. Eisfeld AK, et al. Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation. Am J Blood Res 2012.
  22. Eisfeld AK, et al. Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia. Proc Natl Acad Sci USA 2012.
  23. Eisfeld AK, et al. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood 2012.
  24. Haraldsdottir S, et al. A single institutional experience with panitumumab in metastatic colorectal cancer. Journal of Cancer Therapy 2012.
  25. Kiss DL, et al. Dis3- and exosome subunit-responsive 3’ mRNA instability elements. Biochem Biophys Res Commun 2012.
  26. Mims A, et al. Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: A novel epigenetictargeting approach in acute myeloid leukemia. Leukemia 2012.
  27. Ranganathan P, et al. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 2012.
  28. Ranganathan P, et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood 2012.
  29. Senapati S, et al. Non- Human Prostate Cancer Cell Lines. Oncology, Gastroenterology and Hepatology reports 2012.
  30. Wani NA, et al. Mechanism of intestinal folate transport during folate deficiency in rodent model. Indian J Med Res 2012.
  31. Wani NA, et al. Decreased activity of folate transporters in lipid rafts resulted in reduced hepatic folate uptake in chronic alcoholism in rats. Genes Nutr 2012.
  32. Wani NA, et al. Adaptive transport of folic acid across renal epithelia in folate-deficient rats. J Physiol Sci 2012.
  33. Wani NA, et al. Alcohol associated folate disturbances results in altered methylation of folate regulating genes. Mol Cell Biochem 2012.
  34. Bernardo GM, et al. FOXA1 actively represses the basal breast cancer molecular phenotype. Oncogene 2013.
  35. Bid HK, et al. Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and its Ligands as an Effective Anti-angiogenic Strategy. Clin Cancer Res 2013.
  36. Bid HK, et al. ΔNp63 promotes Childhood Cancers Neuroblastoma and Osteosarcoma by regulating tumor angiogenesis. Cancer Research 2013.
  37. Bid HK, et al. RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis. Mol Can Ther 2013.
  38. DeFraia C, et al. The histone acetyltransferase activity of Elongator subunit 3 is essential for its role in plant immunity. BMC Biology 2013.
  39. Dorrance AM, et al. The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment. Blood 2013.
  40. Galli R, et al. Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression. Proc Natl Acad Sci USA 2013.
  41. Haraldsdottir S, et al. Integrating anti-EGFR therapies in metastatic colorectal cancer. Journal of Gastrointestinal Oncology 2013.
  42. Haraldsdottir S, et al. What is the optimal neo-adjuvant treatment for liver metastases? Therapeutic Advances in Medical Oncology 2013.
  43. Haraldsdottir S, et al. A case of sorafenib-induced thyroid storm. Journal of Clinical Oncology 2013.
  44. Haraldsdottir S, et al. Clinical Indications for ziv-Aflibercept in Colorectal Cancer. International Journal of Targeted Therapies in Cancer 2013.
  45. Hosseini SA, et al. Chromosome fragile sites and genome instability in cells of epithelial origin. Genes Chromosomes Cancer 2013.
  46. Jaremka LM, et al. Marital distress prospectively predicts poorer cellular immune function. Psychoneuroendocrinology 2013.
  47. Jaremka LM, et al. Loneliness promotes inflammation during acute stress. Psychological Science 2013.
  48. Jaremka LM., et al. Synergistic relationships among stress, depression, and troubled relationships: Insights from Psychoneuroimmunology. Depression and Anxiety 2013.
  49. Jaremka LM., et al. Loneliness predicts pain, depression, and fatigue: Understanding the role of immune dysregulation. Psychoneuroendocrinology 2013.
  50. Jaremka LM, et al. Attachment anxiety is linked to alterations in cortisol production and cellular immunity. Psychological Science 2013.
  51. Kaul Z, et al. HECT-E3 ligase ETC-1 regulates the abundance of cytoplasmic securin and cyclin B1 to promote timely anaphase during meiosis in C. elegans. Development 2013.
  52. Li J, et al. Ultrafast Dynamics of Flavins and Flaoproteins. Flavoproteins 2013.
  53. Li J, et al. Resonance Raman Spectroscopy, In: Methods in Molecular Biology: Flavins & Flavoproteins. Humana Press USA 2013.
  54. Markowitz J, et al. Review of S100A9 biology and its role in cancer. Biochimica et biophysica acta 2013.
  55. Markowitz J, et al. Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res Treat 2013.
  56. Martin CK, et al. Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma. Vet Comp Oncol 2013.
  57. Mims A, et al. Developmental therapeutics in acute myelogenous leukemia: are there any new effective cytotoxic chemotherapeutic agents out there? Curr Hematol Malig Rep 2013.
  58. Moran NE, et al. Biosynthesis of highly enriched 13C-lycopene for human metabolic studies using repeated batch tomato cell culturing with 13C-glucose. Food Chem 2013.
  59. Moran NE, et al. Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution. Arch Biochem Biophys 2013.
  60. Moran NE, et al. Differential bioavailability, clearance, and tissue distribution of the acyclic tomato carotenoids lycopene and phytoene in mongolian gerbils. J Nutr 2013.
  61. Okano-Uchida T, et al. Cerebellar neural stem cells differentiate into two distinct types of astrocytes in response to CNTF and BMP2. Neurosci Lett 2013.
  62. Shirley L, et al. Therapeutic endoscopic ultrasonography: intratumoral injection for pancreatic adenocarcinoma. Gastroenterol Res Pract 2013.
  63. Sizemore GM, et al. FOXC1 is enriched in the mammary luminal progenitor population, but is not necessary for mouse mammary ductal morphogenesis. Biology of Reproduction 2013.
  64. Wani NA, et al. Mechanistic insights of intestinal absorption and renal conservation of folate in chronic alcoholism. Alcohol 2013.
  65. Yaseen Balkhi M, et al. The MicroRNA miR-29 Acts as a Decoy to Protect the RNA Encoding Tumor Suppressor and NF-kB Inhibitor A20 from Degradation. Science Signaling 2013.
  66. Yaseen Balkhi M et al. MicroRNA Function in Muscle Homeostasis and Regenerative Medicine. MicroRNAs in Regenerative Medicine 2013.
  67. Cantara WA, et al. Small-angle X-ray scattering-derived structure of the HIV-1 5’ UTR reveals 3D tRNA mimicry. Proc Natl Acad Sci USA 2014.
  68. Eisfeld AK, et al. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway. Science Signaling 2014.
  69. Eisfeld AK, et al. Novel NRAS isoforms differentially affect downstream pathways, cell growth and cell transformation. Proc Natl Acad Sci USA 2014.
  70. Haraldsdottir S, et al. New era for treatment in differentiated thyroid cancer. The Lancet 2014.
  71. Haraldsdottir S, et al. Prostate cancer incidence in males with Lynch syndrome. Genetics in Medicine 2014.
  72. Haraldsdottir S, et al. An update on clinical trials of targeted therapies in thyroid cancer. Current Opinion in Oncology 2014.
  73. Jaremka LM, et al. Cognitive problems among breast cancer survivors: Loneliness enhances risk. Psycho-oncology 2014.
  74. Jaremka LM, et al. Psychoneuroimmunology of interpersonal relationships: Both the presence/absence of social ties and relationship quality matter. Handbook of Behavioral Medicine (Vol 2) 2014.
  75. Jaremka LM, et al. Pain, depression, and fatigue: Loneliness as a longitudinal risk factor. Health Psychology 2014. 
  76. Keplinger KM, et al. Anatomy and embryology of the biliary tract. Surg Clin North Am 2014.
  77. Kovinich N, et al. Not all anthocyanins are born equal: distinct patterns induced by stress in Arabidopsis. Planta 2014.
  78. Markowitz J, et al. A Phase I trial of bortezomib and Interferon-α-2B in metastatic melanoma. J Immunother 2014.
  79. VanGundy ZC*,Markowitz, J*, et al. An in vitro model system to generate breast cancer MDSCs and study immune cell interactions in immunocompetent C57BL/6 mice. J Cancer Biol Res 2014. *Both authors contributed equally
  80. Rocci A, et al. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. Br J Haematol 2014.
  81. Rocci A, et al. Circulating miRNA markers show promise as new prognosticators for multiple myeloma. Leukemia 2014.
  82. Sun RC, et al. Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metabolism 2014.
  83. Wang Y, et al. Quantitative characterization of cell behaviors through cell cycle progression via automated cell tracking, PLOS ONE 2014.
  84. Wani NA, et al. CXCL12/CXCR7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment. Breast Cancer Research 2014

Medical Students

  1. Beckwith KA, et al. The CD37-targeting antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model. Leukemia 2014.

Sign up to receive publications from the OSUCCC – James

Sign Up Now

Contact The James

General Inquiries




460 W. 10th Avenue
Columbus, OH 43210

Contact Us

Meet the Leaders

Leadership & Executive Cabinet at The James

Learn More